These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1733855)

  • 21. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient.
    Aguilar-Martinez P; Romey MC; Gris JC; Schved JF; Demaille J; Claustres M
    Hum Mutat; 1994; 3(2):156-8. PubMed ID: 8199596
    [No Abstract]   [Full Text] [Related]  

  • 23. Point mutations in four hemophilia B patients from China.
    Wang NS; Chen SH; Thompson AR
    Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.
    Crossley M; Ludwig M; Stowell KM; De Vos P; Olek K; Brownlee GG
    Science; 1992 Jul; 257(5068):377-9. PubMed ID: 1631558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
    Tartary M; Vidaud D; Piao Y; Costa JM; Bahnak BR; Fressinaud E; Congard B; Laurian Y; Meyer D; Lavergne JM
    Br J Haematol; 1993 Aug; 84(4):662-9. PubMed ID: 8217825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations.
    Picketts DJ; Mueller CR; Lillicrap D
    Blood; 1994 Nov; 84(9):2992-3000. PubMed ID: 7949171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five novel factor IX mutations in unrelated hemophilia B families.
    Chen SH; Schoof JM; Scott CR; Thompson AR
    Hum Mol Genet; 1993 May; 2(5):599-600. PubMed ID: 8518801
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemophilia B Leyden and once mysterious cis-regulatory mutations.
    Funnell AP; Crossley M
    Trends Genet; 2014 Jan; 30(1):18-23. PubMed ID: 24138812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A less severe form of Haemophilia B Leyden.
    Crossley M; Winship PR; Austen DE; Rizza CR; Brownlee GG
    Nucleic Acids Res; 1990 Aug; 18(15):4633. PubMed ID: 2388855
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular and functional basis of hereditary factor IX defects.
    Walter J
    Wien Klin Wochenschr; 1994; 106(5):141-3. PubMed ID: 8171870
    [No Abstract]   [Full Text] [Related]  

  • 31. Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic.
    Buzin CH; Wen CY; Nguyen VQ; Nozari G; Mengos A; Li X; Chen JS; Liu Q; Gatti RA; Fujimura FK; Sommer SS
    Biotechniques; 2000 Apr; 28(4):746-50, 752-3. PubMed ID: 10769754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usual and unusual mutations in a cohort of Belgian patients with hemophilia B.
    Lannoy N; Lambert C; Farrugia A; Van Damme A; Hermans C
    Thromb Res; 2017 Jan; 149():25-28. PubMed ID: 27865967
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
    Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
    Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Four novel point mutations of factor IX gene detected by denaturing gradient gel electrophoresis].
    Wang Y; Li Z; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):125-8. PubMed ID: 11243142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splice junction mutations in factor IX gene resulting in severe hemophilia B.
    Chen SH; Zhang M; Thompson AR; Bray GL; Scott CR
    Nucleic Acids Res; 1991 Mar; 19(5):1172. PubMed ID: 2020563
    [No Abstract]   [Full Text] [Related]  

  • 37. Two novel factor IX promoter mutations: incremental progress towards 'saturation in vivo mutagenesis' of a human promoter region.
    Ketterling RP; Liu JZ; Liao D; Kasper CK; Ambriz R; Paredes R; Sommer SS
    Hum Mol Genet; 1995 Apr; 4(4):769-70. PubMed ID: 7633432
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel mutations in factor IX gene from western India with reference to their phenotypic and haplotypic attributes.
    Quadros L; Ghosh K; Shetty S
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):157-60. PubMed ID: 19262239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five novel factor IX mutations in unrelated hemophilia B patients.
    David D; Moreira I; Morais S; de Deus G
    Hum Mutat; 1998; Suppl 1():S301-3. PubMed ID: 9452115
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical significance of two mutations in the factor IX gene in a family with haemophilia B.
    Sexton A; Furmedge J; Barnes C; Cheetham G; Wallace J; Savarirayan R
    Haemophilia; 2010 Mar; 16(2):374-6. PubMed ID: 19930472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.